Do antimicrobial development and reimbursement models make sense to payers?

September 8, 2016 (All day) to September 9, 2016 (All day)

525 New Jersey Avenue NW, Washington DC 20001

Speakers

Gabriela Lavezzeri, PhD, MBA, Research Director
Scholar in Residence Edmund Pezalla, MD, MPH

Description

Duke-Margolis' Gabriela Lavezzeri, PhD, MBA, Research Director and Scholar in Residence Edmund Pezalla, MD, MPH will present, "Do antimicrobial development and reimbursement models make sense to payers?" at the World Anti-Microbial Resistance Conference in Washington, DC.  Their panel will take place on September 8, 2016, at 11:50 am.